These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 36214477)

  • 21. Representativeness of the GALACTIC-HF Clinical Trial in Patients Having Heart Failure With Reduced Ejection Fraction.
    Mefford MT; Koyama SY; De Jesus J; Wei R; Fischer H; Harrison TN; Woo P; Reynolds K
    J Am Heart Assoc; 2022 Apr; 11(7):e023766. PubMed ID: 35322672
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Electronic Alerts to Improve Heart Failure Therapy in Outpatient Practice: A Cluster Randomized Trial.
    Ghazi L; Yamamoto Y; Riello RJ; Coronel-Moreno C; Martin M; O'Connor KD; Simonov M; Huang J; Olufade T; McDermott J; Dhar R; Inzucchi SE; Velazquez EJ; Wilson FP; Desai NR; Ahmad T
    J Am Coll Cardiol; 2022 Jun; 79(22):2203-2213. PubMed ID: 35385798
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Guideline-directed medical therapy in elderly patients with heart failure with reduced ejection fraction: a cohort study.
    Seo WW; Park JJ; Park HA; Cho HJ; Lee HY; Kim KH; Yoo BS; Kang SM; Baek SH; Jeon ES; Kim JJ; Cho MC; Chae SC; Oh BH; Choi DJ
    BMJ Open; 2020 Feb; 10(2):e030514. PubMed ID: 32034017
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Optimal Heart Failure Medical Therapy and Mortality in Survivors of Cardiogenic Shock: Insights From the FRENSHOCK Registry.
    Matsushita K; Delmas C; Marchandot B; Roubille F; Lamblin N; Leurent G; Levy B; Elbaz M; Champion S; Lim P; Schneider F; Khachab H; Carmona A; Trimaille A; Bourenne J; Seronde MF; Schurtz G; Harbaoui B; Vanzetto G; Biendel C; Labbe V; Combaret N; Mansourati J; Filippi E; Maizel J; Merdji H; Lattuca B; Gerbaud E; Bonnefoy E; Puymirat E; Bonello L; Morel O
    J Am Heart Assoc; 2024 Mar; 13(5):e030975. PubMed ID: 38390813
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prescription Rates and Prognostic Implications of Optimally Targeted Guideline-Directed Medical Treatment in Heart Failure and Atrial Fibrillation: Insights From The MISOAC-AF Trial.
    Moysidis DV; Kartas A; Samaras A; Papazoglou AS; Patsiou V; Bekiaridou A; Baroutidou A; Tsagkaris C; Karagiannidis E; Daios S; Anastasiou V; Tsalikakis D; Efthimiadis G; Ziakas A; Tzikas A; Giannakoulas G
    J Cardiovasc Pharmacol; 2023 Mar; 81(3):203-211. PubMed ID: 36626410
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Representativeness of the PIONEER-HF Clinical Trial Population in Patients Hospitalized With Heart Failure and Reduced Ejection Fraction.
    Fudim M; Sayeed S; Xu H; Matsouaka RA; Heidenreich PA; Velazquez EJ; Yancy CW; Fonarow GC; Hernandez AF; DeVore AD
    Circ Heart Fail; 2020 Apr; 13(4):e006645. PubMed ID: 32248695
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rationale and design of a cluster-randomized pragmatic trial aimed at improving use of guideline directed medical therapy in outpatients with heart failure: PRagmatic trial of messaging to providers about treatment of heart failure (PROMPT-HF).
    Ghazi L; Desai NR; Simonov M; Yamamoto Y; O'Connor KD; Riello RJ; Huang J; Olufade T; McDermott J; Inzucchi SE; Velazquez EJ; Wilson FP; Ahmad T
    Am Heart J; 2022 Feb; 244():107-115. PubMed ID: 34808104
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic impact of acute decompensated heart failure in patients with heart failure with mildly reduced ejection fraction.
    Schmitt A; Schupp T; Reinhardt M; Abel N; Lau F; Forner J; Ayoub M; Mashayekhi K; Weiß C; Akin I; Behnes M
    Eur Heart J Acute Cardiovasc Care; 2024 Feb; 13(2):225-241. PubMed ID: 37950915
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of adherence to guideline-directed therapy on risk of death in HF patients across an ejection fraction spectrum.
    Chen X; Kang Y; Dahlström U; Fu M
    ESC Heart Fail; 2023 Dec; 10(6):3656-3666. PubMed ID: 37803813
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Early and long-term outcomes of decompensated heart failure patients in a tertiary-care centre in India.
    Ganapathi S; Jeemon P; Krishnasankar R; Kochumoni R; Vineeth P; Mohanan Nair KK; Valaparambil AK; Harikrishnan S
    ESC Heart Fail; 2020 Apr; 7(2):467-473. PubMed ID: 32012491
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Contemporary guideline-directed medical therapy in de novo, chronic, and worsening heart failure patients: First data from the TITRATE-HF study.
    Malgie J; Wilde MI; Clephas PRD; Emans ME; Koudstaal S; Schaap J; Mosterd A; van Ramshorst J; Wardeh AJ; van Wijk S; van den Heuvel M; Wierda E; Borleffs CJW; Saraber C; Beeres SLMA; van Kimmenade R; Jansen Klomp W; Denham R; da Fonseca CA; Klip IT; Manintveld OC; van der Boon RMA; van Ofwegen CEE; Yilmaz A; Pisters R; Linssen GCM; Faber N; van Heerebeek L; van de Swaluw JEC; Bouhuijzen LJ; Post MC; Kuijper AFM; Wu KW; van Beek EA; Hesselink T; Kleijn L; Kurvers MJM; Tio RA; Langerveld J; van Dalen BM; van Eck JWM; Handoko ML; Hermans WRM; Koornstra-Wortel HJJ; Szymanski MK; Rooker D; Tandjung K; Eijsbouts SCM; Asselbergs FW; van der Meer P; Brunner-La Rocca HP; de Boer RA; Brugts JJ
    Eur J Heart Fail; 2024 Jul; 26(7):1549-1560. PubMed ID: 38734980
    [TBL] [Abstract][Full Text] [Related]  

  • 32. National Heart Failure Registry, India: Design and methods.
    Harikrishnan S; Bahl A; Roy A; Mishra A; Prajapati J; Nanjappa MC; Sethi R; Guha S; Satheesh S; Chacko M; Ganapathi S; Jeemon P
    Indian Heart J; 2019; 71(6):488-491. PubMed ID: 32248923
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Guideline implementation, drug sequencing, and quality of care in heart failure: design and rationale of TITRATE-HF.
    Clephas PRD; Malgie J; Schaap J; Koudstaal S; Emans M; Linssen GCM; de Boer GA; van Heerebeek L; Borleffs CJW; Manintveld OC; van Empel V; van Wijk S; van den Heuvel M; da Fonseca C; Damman K; van Ramshorst J; van Kimmenade R; van de Ven ART; Tio RA; van Veghel D; Asselbergs FW; de Boer RA; van der Meer P; Greene SJ; Brunner-La Rocca HP; Brugts JJ
    ESC Heart Fail; 2024 Feb; 11(1):550-559. PubMed ID: 38064176
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characteristics, Outcomes, and Treatment of Heart Failure With Improved Ejection Fraction.
    Park CS; Park JJ; Mebazaa A; Oh IY; Park HA; Cho HJ; Lee HY; Kim KH; Yoo BS; Kang SM; Baek SH; Jeon ES; Kim JJ; Cho MC; Chae SC; Oh BH; Choi DJ
    J Am Heart Assoc; 2019 Mar; 8(6):e011077. PubMed ID: 30845873
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparative Effectiveness of Dosing of Medical Therapy for Heart Failure: From the CHAMP-HF Registry.
    Greene SJ; Butler J; Hellkamp AS; Spertus JA; Vaduganathan M; Devore AD; Albert NM; Patterson JH; Thomas L; Williams FB; Hernandez AF; Fonarow GC
    J Card Fail; 2022 Mar; 28(3):370-384. PubMed ID: 34793971
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The role of a multidisciplinary heart failure clinic in optimization of guideline-directed medical therapy: HF-optimize.
    Diederich T; Burdorf A; Pozehl B; Bowman S; Ferguson K; Holder K; Alonso W; Stoller D; Lundgren S
    Heart Lung; 2023; 57():95-101. PubMed ID: 36088681
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical profile and one-year survival of patients with heart failure with reduced ejection fraction: The largest report from India.
    Chopra VK; Mittal S; Bansal M; Singh B; Trehan N
    Indian Heart J; 2019; 71(3):242-248. PubMed ID: 31543197
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Validation of a New Scoring Method to Assess the Efficacy of Rapid Initiation and Titration of Combination Pharmacotherapy for Patients Hospitalized with Acute Decompensated Heart Failure with Reduced and Mildly Reduced Ejection Fraction.
    Asano T; Maeno Y; Nakano M; Taguri M; Miyasaka M; Nakai D; Miyazaki I; Nasu T; Tanimoto S; Masuda N; Morino Y; Isshiki T; Ogata N
    J Clin Med; 2024 May; 13(10):. PubMed ID: 38792317
    [No Abstract]   [Full Text] [Related]  

  • 39. Heart failure ejection fraction class conversions: impact of biomarkers, co-morbidities, and pharmacotherapy.
    Lorenzo CJ; Conte JI; Villasmil RJ; Abdelal QK; Pierce D; Wiese-Rometsch W; Garcia-Fernandez JA
    ESC Heart Fail; 2022 Aug; 9(4):2538-2547. PubMed ID: 35570322
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Regional Variation of Mortality in Heart Failure With Reduced and Preserved Ejection Fraction Across Asia: Outcomes in the ASIAN-HF Registry.
    MacDonald MR; Tay WT; Teng TK; Anand I; Ling LH; Yap J; Tromp J; Wander GS; Naik A; Ngarmukos T; Siswanto BB; Hung CL; Richards AM; Lam CSP; ;
    J Am Heart Assoc; 2020 Jan; 9(1):e012199. PubMed ID: 31852421
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.